Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Faden

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Bipolar Disorders|February 15, 2025
Long-Acting Injectables: A Strategy to Mitigate Nonadherence in Bipolar DisorderJustin Faden, Elina Maymind
Therapeutic Advances in Psychopharmacology|November 23, 2020
Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?Justin Faden, Leslie Citrome
Current Medical Research and Opinion|March 24, 2025
A new paliperidone palmitate formulation: how is it different and where does it fit in our array of choices for long-acting formulations of risperidone and paliperidone?Justin Faden, Leslie Citrome
Neuropsychiatric Disease and Treatment|September 10, 2019
Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adultsJustin Faden, Leslie Citrome
American Family Physician|September 15, 2018
The Doorknob Phenomenon in Clinical PracticeJustin Faden, Gregg Gorton
The Primary Care Companion for CNS Disorders|April 9, 2016
Dextromethorphan/Quinidine For Neuropsychiatric Manifestations of Wilson's DiseaseJustin Faden, John P O'Reardon
Expert Review of Neurotherapeutics|March 31, 2022
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?Justin Faden, Ryan Serdenes, Leslie Citrome
Therapeutic Advances in Psychopharmacology|September 20, 2021
Asenapine: an atypical antipsychotic with atypical formulationsMeghan Musselman, Justin Faden, Leslie Citrome
Expert Review of Neurotherapeutics|January 27, 2023
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agentJustin Faden, Meghan Musselman, Leslie Citrome
The Journal of Nervous and Mental Disease|January 2, 2024
"The Demons Made Me Do It": When Delusions of Possession Lead to Attempted Inpatient SuicideJacob R Weiss, Monica Sharobeam, Justin Faden
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Bipolar Disorders|February 15, 2025
Long-Acting Injectables: A Strategy to Mitigate Nonadherence in Bipolar DisorderJustin Faden, Elina Maymind
Therapeutic Advances in Psychopharmacology|November 23, 2020
Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?Justin Faden, Leslie Citrome
Current Medical Research and Opinion|March 24, 2025
A new paliperidone palmitate formulation: how is it different and where does it fit in our array of choices for long-acting formulations of risperidone and paliperidone?Justin Faden, Leslie Citrome
Neuropsychiatric Disease and Treatment|September 10, 2019
Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adultsJustin Faden, Leslie Citrome
American Family Physician|September 15, 2018
The Doorknob Phenomenon in Clinical PracticeJustin Faden, Gregg Gorton
The Primary Care Companion for CNS Disorders|April 9, 2016
Dextromethorphan/Quinidine For Neuropsychiatric Manifestations of Wilson's DiseaseJustin Faden, John P O'Reardon
Expert Review of Neurotherapeutics|March 31, 2022
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?Justin Faden, Ryan Serdenes, Leslie Citrome
Therapeutic Advances in Psychopharmacology|September 20, 2021
Asenapine: an atypical antipsychotic with atypical formulationsMeghan Musselman, Justin Faden, Leslie Citrome
Expert Review of Neurotherapeutics|January 27, 2023
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agentJustin Faden, Meghan Musselman, Leslie Citrome
The Journal of Nervous and Mental Disease|January 2, 2024
"The Demons Made Me Do It": When Delusions of Possession Lead to Attempted Inpatient SuicideJacob R Weiss, Monica Sharobeam, Justin Faden
Pageof 4